Publikationen, an denen er mitarbeitet Vanessa Roldan Schilling (4)

2016

  1. Genotype-guided therapy improves initial acenocoumarol dosing: Results from a prospective randomised study

    Thrombosis and Haemostasis, Vol. 115, Núm. 1, pp. 117-125

2014

  1. Effect of VKORC1, CYP2C9 and CYP4F2 genetic variants in early outcomes during acenocoumarol treatment

    Pharmacogenomics, Vol. 15, Núm. 7, pp. 987-996

2013

  1. Creating a genotype-based dosing algorithm for acenocoumarol steady dose

    Thrombosis and Haemostasis, Vol. 109, Núm. 1, pp. 146-153

  2. Novel Associations of VKORC1 Variants with Higher Acenocoumarol Requirements

    PLoS ONE, Vol. 8, Núm. 5